55 11 3061 7457 Fax: +55 11 3081 7190 [email protected] Establishing that TNF-α plays an important ... led to the development of neutralizing anti-TNF-α antibodies for the treatment of patients ...
Monitoring individuals with robust and clinically validated tests for both drugs and antidrug antibodies is the only way to ensure cost-effective, long-term use of anti-TNF-α biopharmaceuticals.
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...
GlobalData on MSN7d
Bio-Thera signs US deal with Intas for golimumab biosimilarBio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.
Death receptor 3 (DR3) is the only signaling receptor for TNF superfamily ligand TL1A, the dysregulation of which has been implicated in multiple inflammatory diseases such as inflammatory bowel ...
Sino Biological offers a comprehensive selection of recombinant TNF and TNFR proteins and corresponding antibodies that support drug discovery and development research on TNFs/TNFRs. TNFRSF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback